Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways

The use of peptides that target cancer cells and induce anticancer activities through various mechanisms is developing as a potential anticancer strategy. KUD983, an enantiomerically pure β-dipeptide derivative, displays potent activity against hormone-refractory prostate cancer (HRPC) PC-3 and DU14...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Mei-Ling, Yu, Chia-Chun, Hsu, Jui-Ling, Leu, Wohn-Jenn, Chan, She-Hung, Hsu, Lih-Ching, Liu, Shih-Ping, Ivantcova, Polina M., Dogan, Özdemir, Bräse, Stefan, Kudryavtsev, Konstantin V., Guh, Jih-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722513/
https://www.ncbi.nlm.nih.gov/pubmed/29228561
http://dx.doi.org/10.18632/oncotarget.18040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722513/
https://www.ncbi.nlm.nih.gov/pubmed/29228561
http://dx.doi.org/10.18632/oncotarget.18040

Ejemplares similares